THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Amgen Inc. (AMGN) on Tuesday reported fourth-quarter profit of $627 million.
The Thousand Oaks, California-based company said it had net income of $1.16 per share. Earnings, adjusted for non-recurring costs, came to $5.31 per share.
The results surpassed Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $5.03 per share.
The world's largest biotech drugmaker posted revenue of $9.09 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $8.86 billion.
Amgen expects full-year earnings in the range of $20 to $21.20 per share, with revenue in the range of $34.3 billion to $35.7 billion.
Amgen shares have risen 11% since the beginning of the year, while the S&P's 500 index has increased 27%. In the final minutes of trading on Tuesday, shares hit $288.59, a decrease of 10% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMGN at https://www.zacks.com/ap/AMGN
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。